George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPATH.L Regulatory News (PATH)

  • There is currently no data for PATH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results for the six months to 30 June 2021

29 Sep 2021 07:00

RNS Number : 2820N
Path Investments plc
29 September 2021
 

29 September 2021

Path Investments plc

("Path" or the "Company")

 

Interim Results for the six months to 30 June 2021

 

Path Investments plc (TIDM: PATH), the energy investment company, announces its interim results for the six months to 30 June 2021.

 

Highlights

 

Successful equity fundraising in March 2021

Conditional Reverse Takeover of DG Innovate Limited ("DGI") announced.

Loss before tax £736,254 (H1 2020 loss before tax of £163,699)

Loss per share 0.04 (H1 2020 loss 0.08 per share)

 

Commenting, Christopher Theis, Chief Executive of Path, said: "The first half of 2021 has been transformational for Path, both financially and strategically. We are very excited about our intended acquisition and welcoming the DGI business with its sustainable global energy technologies into Path."

 

Enquiries:

 

Path Investments plc

C/O IFC

Christopher Theis

 

Jack Allardyce

 

 

 

IFC Advisory (Financial PR & IR)

020 3934 6630

Tim Metcalfe

 

Zach Cohen

 

 

 

Grant Thornton UK LLC (Financial Adviser)

Samantha Harrison

Harrison Clarke

020 7383 5100

 

Lukas Girzadas

 

 

 

ETX Capital (Broker)

 

Tom Curran

020 7392 1400

Thomas Smith

 

 

 

 

About Path Investments plc

 

The strategy of the Company is focused on delivering a material acquisition in the energy sector with the objective of providing the Company's shareholders with access to a low risk and, over time, diversified portfolio which can offer a dividend stream as well as offering development potential for capital growth.

 

 

 

Chairman's Report

 

In March 2021 the Company was delighted to receive the welcome support of new shareholders and certain existing holders in a fund raising with gross proceeds of £3.87 million received to accelerate the Company's investment strategy. We said at the time that we were focussed on one opportunity and anticipated updating shareholders in due course.

 

Post the accounting period on 13th August 2021 we announced our conditional agreement to acquire DG Innovate Limited for £32 million to be satisfied by the issue of 5,342,051,305 Path Ordinary Shares of £0.001 each ("Path Shares") at an issue price of 0.6 pence per Path Share, which compares favourably with the suspension price of 0.27 per Path share.

 

Further details of the transaction are contained on our website https://www.pathinvestmentsplc.com/proposed-acquisition-of-dg-innovate/

 

As part of the acquisition of DGI, and post the accounting period, Path provided from its cash resources a secured loan facility to DGI of £600,000. The facility was made available in two tranches, both of which have now been released to DGI.

 

Work is progressing towards completion of the proposed transaction which constitutes a reverse takeover under the Listing Rules, as it will result in a fundamental change in the business of the Company. We are making good progress on finalising the necessary prospectus and shareholder documentation and we expect to be submitting it shortly for FCA approval.

 

The transaction is also subject to waiver of Rule 9 of the Takeover Code by the Takeover Panel and therefore the approval of Path's independent shareholders at a General Meeting which will be convened for the purpose.

 

We look forward to updating shareholders further as we move towards completion of our transaction.

 

 

Brent Fitzpatrick

Non-Executive Chairman

29 September 2021

 

 

Financial Review

 

For the six months to 30 June 2021, the Company recorded a loss before tax of £736,254. There was no revenue in the period.

 

Cash flow

 

As at 30 June 2021 the Company held cash of £2,267,137 in the bank account.

 

 

 

PATH INVESTMENTS PLC

 

STATEMENT OF COMPREHENSIVE INCOME

FOR THE SIX MONTHS ENDED 30 JUNE 2021

 

 

 

 

 

Notes

Six months ended

30 June

Six months ended

30 June

Year ended 31 December

 

 

2021

2020

2020

 

 

Unaudited

Unaudited

Audited

 

 

£

£

£

Administrative expenses

3

(736,254)

(163,699)

(266,693)

Total administrative expenses

 

(736,254)

(163,699)

(266,693)

 

 

 

 

 

 

 

 

 

 

Operating loss

 

(736,254)

(163,699)

(266,693)

 

 

 

 

 

Finance income

 

-

-

-

Finance cost

 

-

-

(110,410)

 

 

 

 

 

Profit/(loss) on ordinary activities before taxation

 

(736,254)

(163,699)

(377,103)

 

 

 

 

 

Tax on profit/(loss) on ordinary activities

 

-

-

-

 

 

 

 

 

Profit/(loss) for the period and total comprehensive (loss)/profit for period

 

(736,254)

(163,699)

(377,103)

 

 

 

 

 

 

 

 

 

 

Earnings/(loss) per share (pence)

 

 

 

 

- Basic & diluted

4

(0.001)

(0.080)

(0.192)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

All operating income and operating gains and losses relate to continuing activities.

 

 

 

 

STATEMENT OF CHANGES IN EQUITY

FOR THE SIX MONTHS ENDED 30 JUNE 2021

 

 

 

 

 

Share Capital

Share Premium

Capital redemption reserve

Retained earnings

Total

 

£

£

£

£

£

As at 1 January 2021

202,610

25,456,950

8,783,824

(36,588,172)

(2,144,788)

Comprehensive income

Loss for the period

 

 

 

-

 

(736,254)

 

(736,254)

 

 

 

 

 

 

Transactions with owners

 

 

 

 

 

Share based payments

 

 

 

1,238,332

1,238,332

Share issue

1,826,854

2,051,162

-

-

3,878,016

 

 

 

 

 

 

As at 30 June 2021

2,029,464

27,508,112

8,783,824

(36,086,094)

(2,235,305)

 

 

 

 

 

Share Capital

Share Premium

Capital redemption reserve

Retained earnings

Total

 

£

£

£

£

£

As at 1 January 2020

8,979,767

25,413,617

-

(36,298,570)

(1,905,186)

Comprehensive income

Loss for the period

 

-

 

-

 

-

 

(377,103)

 

(317,647)

Share based payments

-

-

-

87,501

87,501

 

 

 

 

 

 

Transactions with owners

 

 

 

 

 

Issue of share capital

6,667

43,333

-

-

50,000

Cancellation of deferred shares

(8,783,824)

-

8,783,824

-

-

 

 

 

 

 

 

As at 31 December 2020

202,610

25,456,950

8,783,824

(36,588,172)

(2,144,788)

 

 

 

 

Share Capital

Share Premium

Capital redemption reserve

Retained earnings

Total

 

£

£

 

£

£

As at 1 January 2020

8,979,767

25,413,617

 

(36,298,570)

(1,587,539)

Comprehensive income

Profit for the period

 

-

 

-

 

 

(163,699)

 

(163,699)

 

 

 

 

 

 

Transactions with owners

 

 

 

 

 

Issue of share capital

67

49,933

 

-

(50,000)

As at 30 June 2020

8,979,834

25,463,550

 

(36,462,269)

(2,018,885)

 

 

The Share Capital represents the nominal value of the equity shares.

 

The Share Premium represents the amount subscribed for share capital, in excess of the nominal amount, less costs directly relating to the issue of shares.

The Share Based Payments reserve represents the fair value of the equity settled share option scheme.

 

The Retained Earnings reserve represents the cumulative net gains and losses less distributions made.

 

 

 

 

statement of financial position

FOR THE SIX MONTHS ENDED 30 JUNE 2021

 

 

 

 

Notes

As at

30 June

2021

As at

30 June

2020

As at

31 December

2020

 

 

Unaudited

Unaudited

Audited

 

 

£

£

£

 

 

 

 

 

ASSETS

 

 

 

 

Fixed assets

 

85,754

-

-

 

 

 

 

 

Current assets

 

 

 

 

Trade and other receivables

 

44,800

6,528

-

Cash and cash equivalents

 

2,267,137

63,934

468

 

 

2,311,937

70,462

468

LIABILITIES

 

 

 

 

Current liabilities

 

 

 

 

Trade and other payables

7

(162,386)

(2,089,347)

(2,145,256)

Net Current Liabilities

 

(162,386)

(2,089,347)

(2,145,256)

 

 

 

 

 

NET LIABILITIES

 

2,235,305

(2,018,885)

(2,144,788)

 

SHAREHOLDERS' EQUITY

 

 

 

 

Called up share capital

8

2,029,464

196,010

202,610

Deferred shares

8

-

8,783,824

-

Capital redemption reserve

 

8,783,824

-

8,783,824

Share premium account

 

27,508,112

25,463,550

25,456,950

Retained earnings

 

(36,086,094)

(36,462,269)

(36,588,172)

TOTAL EQUITY

 

2,235,305

(2,018,885)

(2,144,788)

 

 

 

 

 

 

 

 

 

 

 

statement of cash flows

FOR THE SIX MONTHS ENDED 30 JUNE 2021

 

 

 

 

Six months to 30 June 2021

Six months to 30 June 2020

Year ended 31 December

2020

 

 

Unaudited

Unaudited

Audited

 

 

£

£

£

Operating loss

 

(736,254)

(163,699)

(266,693)

(Increase)/Decrease in debtors

 

(44,800)

3,528

10,056

(Decrease)/increase in creditors within one year

 

 

(1,932,870)

 

123,943

 

124,852

Share based payments

 

1,238,332

-

87,501

Convertible loan note interest

 

-

-

(110,000)

 

 

 

 

 

Net cash outflow from operating activities

 

(1,475,592)

(36,228)

(154,284)

 

 

 

 

 

 

 

 

 

 

Cash flows from investing activities

 

 

 

 

Purchase of fixed assets

 

(85,754)

 

 

Finance costs

 

-

-

(410)

Net cash generated from investing activities

 

 

(85,754)

 

-

 

399,890

 

 

 

 

 

Cash flows from financing activities

 

 

 

 

Decrease in bank borrowings

 

(50,000)

50,000

50,000

Issue of share capital

 

3,878,015

50,000

50,000

Issue of convertible loans

 

-

-

55,000

Net cash generated from financing activities

 

 

3,828,015

 

100,000

 

155,000

 

 

 

 

 

Net increase/(decrease) in cash and cash equivalents

 

2,266,669

63,772

306

Cash and cash equivalents at beginning of period

 

468

162

162

Cash and cash equivalents at end of period

 

2,267,137

63,934

468

 

 

 

 

 

 

 

 

 

PATH INVESTMENTS PLC

 

notes to the accounts

FOR THE SIX MONTHS ENDED 30 JUNE 2021

 

 

1. GENERAL INFORMATION

 

Path Investments Plc is a public limited company incorporated in the United Kingdom, registered under company number 04006413. The address of the registered office is 15 Victoria Mews, Millfield Road, Cottingley Business Park, Bingley, West Yorkshire, BD16 1PY. The principal activity of the Company is the investment in natural resources production and development assets.

 

2. ACCOUNTING POLICIES

 

2.1 Basis of preparation

 

The condensed interim financial statements are presented in UK Sterling and all values are rounded to the nearest pound except where indicated otherwise.

 

The condensed interim financial statements have been prepared under the historical cost convention or fair value where appropriate.

 

The results for the six months to 30 June 2021 have been prepared on the basis of the accounting policies set out in the company's 2020 annual report and accounts. The interim accounts do not constitute statutory accounts as defined by section 434 of the Companies Act 2006. The auditor has reported on the 2020 accounts and the report was unqualified and did not contain a statement under section 498(2) of (3) of the Companies Act 2006. The company's 2020 report and accounts have been filed with the registrar of companies.

 

During the period, there have been no changes in the nature of the related party transactions from those described in the company's 2020 accounts.

 

 

2.2 Responsibility statement

 

The directors confirm that these condensed interim financial statements have been prepared in accordance with International Accounting Standard 34 "Interim Financial Reporting", as adopted by the United Kingdom and as issued by the IASB and that the interim management report includes a fair review of the information required by DTR 4.2.7R and DTR 4.2.8R, namely;

 

a) An indication of the important events that have occurred during the first six months and their impact on the condensed set of financial statements, and a description of the principal risks and uncertainties for the remaining six months of the financial year; and

 

b) Material related party transactions in the first six months and any material changes in related party transactions described in the last annual report.

 

3. ADMINISTRATIVE EXPENSES

 

 

Six months to 30 June 2021

Six months to 30 June 2020

Year ended 31 December

2020

 

Unaudited

Unaudited

Audited

 

£

£

£

Directors remuneration

246,784

82,790

454,205

Other administrative expenses

489,470

80,909

(187,512)

 

736,254

163,699

266,693

 

 

Included in Directors remuneration for the period ended 30 June 2021 are accrued salaries of £nil (June 2020 £82,790, December 2020: £454,205).

 

 

4. LOSS PER SHARE

 

The calculation of the basic and diluted loss per share is based on the loss on ordinary activities after taxation of and on the weighted average number of ordinary shares in issue.

 

There was no dilutive effect from the share options or convertible loan notes outstanding during the period.

 

In order to calculate the diluted earnings per share, the weighted average number of ordinary shares in issue is adjusted to assume conversion of all dilutive potential ordinary shares according to IAS33. Dilutive potential ordinary shares include convertible loan notes and share options granted to Directors and consultants where the exercise price (adjusted according to IAS 33) is less than the average market price of the Company's ordinary shares during the period.

 

 

 

Six months to 30 June 2021

Six months to 30 June 2020

Year ended 31 December

2020

 

Unaudited

Unaudited

Audited

 

£

£

£

Net profit/(loss) for the period

(736,254)

(163,699)

(377,103)

 

 

 

 

The weighted average number of shares in the period were:

 

 

 

 

 

 

 

Basic and dilutive ordinary shares

1,109,403,803

207,410,469

195,977,136

 

 

 

 

Basic and dilutive earnings/(loss) per share (pence)

(0.001)

(0.080)

(0.192)

 

 

5. FIXED ASSETS

 

 

 

Motor Vehicles

TOTAL

 

 

£

£

 

 

 

 

Cost

 

 

 

At 1 Jan 2021 (audited)

 

-

-

Additions

 

85,754

85,754

 At 30 Jun 2021 (unaudited)

 

85,754

85,754

 

 

 

 

Depreciation

 

 

 

Depreciation at 1 Jan 2021 (audited)

 

-

-

Charge in the period

 

-

-

Depreciation at 30 Jun 2021(unaudited)

 

-

-

 

 

 

 

Carrying value

 

 

 

At 30 June 2021 (unaudited)

 

85,754

85,754

At 30 June 2020 (unaudited)

 

-

-

 At 31 Dec 2020 (audited)

 

-

-

 

 

 

 

 

 

 

 

 

 

 

6. TRade and other RECEIVABLES

 

 

As at 30

June

2021

As at 30

June

2020

As at 31 December 2020

 

Unaudited

Unaudited

Audited

 

 

£

£

 

 

 

 

Other receivables

44,800

6,528

-

 

44,800

6,528

-

 

7. TRade and other payables

 

 

As at 30

June

2021

As at 30

June

2020

As at 31 December 2020

 

Unaudited

Unaudited

Audited

 

 

£

£

 

 

 

 

Trade payables

155,886

322,338

365,659

Other payables

-

292,830

457,830

Bank loan

-

-

50,000

Accruals and deferred income

6,500

1,424,179

1,271,767

 

 

162,386

2,089,347

2,145,256

 

8. SHARE Capital

 

 

 

 

 

 

 

 

 

 

Unaudited

Unaudited

Unaudited

Unaudited

Allotted, called up and fully paid

 

 

No

£

no

£

 

 

 

Ordinary Shares of 0.1p each

Ordinary Shares of 0.1p each

Deferred Share of 39.9p each

Deferred Share of 39.9p each

 

At 1 January 2020 (audited)

 

 

 

195,943,802

 

195,943

 

22,014,596

 

8,783,824

Issued in period

 

 

6,666,667

67

-

-

Cancellation of shares

 

 

 

 

(22,014,596)

(8,783,824)

 

At 31 December 2020 (audited)

 

 

 

202,610,469

 

202,610

 

-

 

-

 

 

 

 

 

 

 

At 1 January 2021

 

 

202,610,469

202,610

-

-

Issued in period

 

 

1,826,853,333

1,826,855

 

 

 

 

At 30 June 2021 (unaudited)

 

 

 

2,029,463,802

 

2,029,465

 

-

 

-

 

 

 

9. related party transactions

 

The following share options were held by the directors during the year:

 

Director

Date of grant

Held at 1 January 2021

Surrendered during the year

Granted during the Period

Held at 30 June

2021

Exercise price

C Theis

08/10/2020

42,500,000

-

-

42,500,000

£0.001

 

18/03/2021

-

-

739,520,000

739,520,000

£0.001

N Fitzpatrick

18/03/2021

-

-

162,820,000

162,820,000

£0.001

J Allardyce

18/03/2021

-

-

62,500,000

62,500,000

£0.001

Total

 

42,500,000

-

964,840,000

1,007,340,000

 

 

As at 30 June 2021, included in other payables were the following convertible loan notes issued to the Directors together with accrued interest thereon.

 

Outstanding at 31 December 2020

Convertible loan notes issued during period

Interest accrued during the period

Converted during the period

Repaid during the period

Outstanding at 30 June 2021

Director

£

£

£

£

£

£

C Theis*

150,000

-

-

-

(150,000)-

-

C Theis

3,000

-

-

(3,000)

-

-

A Yeo

75,000

-

-

(75,000)

-

-

N Fitzpatrick

54,000

-

-

(54,000)

-

-

J Allardyce

-

15,000

-

(15,000)

-

-

Total

282,000

15,000

-

(147,000)

(150,000)

-

 

* these loan notes were issued to Networkguru Limited, a company owned by Chris's Theis' son, who subscribed under the convertible loan note instrument.

 

The convertible loans were either all converted or repaid within the period.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR LPMFTMTBTBRB
Date   Source Headline
7th Apr 20227:00 amRNSUpdate on Acquisition
5th Apr 20227:00 amRNSInvestor Presentation
1st Apr 20222:45 pmRNSResult of General Meeting
14th Mar 20221:09 pmRNSPublication of Prospectus, Notice of GM, Fundraise
1st Feb 20227:00 amRNSProposed Transaction Update
31st Dec 20217:00 amRNSProposed Transaction Update
18th Nov 20217:00 amRNSAppointment of Joint Broker
26th Oct 20217:00 amRNSProposed Transaction Update
13th Oct 20216:02 pmRNSCorrection: Holding(s) in Company
13th Oct 20214:52 pmRNSHolding(s) in Company
11th Oct 20217:00 amRNSBlock listing Interim Review
29th Sep 20217:00 amRNSInterim Results for the six months to 30 June 2021
28th Sep 20212:45 pmRNSResult of AGM
22nd Sep 20212:41 pmRNSFurther secured loan provided to DG Innovate
9th Sep 20216:01 pmRNSHolding(s) in Company
2nd Sep 20217:00 amRNSNotice of AGM
18th Aug 202111:54 amRNSCorrection: Holding(s) in Company
18th Aug 20217:00 amRNSHolding(s) in Company
13th Aug 20217:45 amRNSProposed Acquisition of DG Innovate & Suspension
14th Jul 20215:23 pmRNSHolding(s) in Company
14th Jul 20212:39 pmRNSHolding(s) in Company
24th Jun 20217:00 amRNSFinal Results for the Year Ended 31 December 2020
16th Jun 20217:00 amRNSHolding(s) in Company
8th Jun 202111:49 amRNSHolding(s) in Company
7th Jun 202112:04 pmRNSHolding(s) in Company
9th Apr 202110:03 amRNSHolding(s) in Company
9th Apr 20217:00 amRNSBlock Listing
1st Apr 20215:02 pmRNSHolding(s) in Company
31st Mar 20219:55 amRNSTotal Voting Rights
24th Mar 20212:06 pmRNSDirector/PDMR Share Transaction
19th Mar 20218:53 amRNSHolding(s) in Company
12th Mar 20215:36 pmRNSAdmission of previously issued shares
12th Mar 202112:50 pmRNSPublication of Prospectus
8th Mar 202111:05 amRNSSecond Price Monitoring Extn
8th Mar 202111:00 amRNSPrice Monitoring Extension
1st Mar 20214:41 pmRNSSecond Price Monitoring Extn
1st Mar 20214:36 pmRNSPrice Monitoring Extension
26th Feb 20212:06 pmRNSSecond Price Monitoring Extn
26th Feb 20212:00 pmRNSPrice Monitoring Extension
26th Feb 20217:00 amRNSEquity Fundraise Update
19th Feb 20217:00 amRNS£3.5 million Equity Fundraise
15th Feb 20212:00 pmRNSTermination of DTU Acquisition
3rd Dec 20209:44 amRNSSubscription for £55,000 of Convertible Loan Stock
5th Nov 20207:00 amRNSFurther re the Acquisition of 75% of DT Ultravert
8th Oct 20209:55 amRNSOption Surrender and Issue of Replacement Options
5th Oct 20207:00 amRNSProposed sale of Kansas Land Leases and equipment
1st Oct 202011:41 amRNSFurther re the Acquisition of DT Ultravert
30th Sep 20207:00 amRNSBoard Changes & Acquisition of Deferred Shares
10th Sep 20201:30 pmRNSInterim Results for the six months to 30 June 2020
10th Sep 20201:15 pmRNSFinal Results for the Year Ended 31 December 2019

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.